Your browser doesn't support javascript.
loading
Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol.
Hoon, Siao Nge; Fyfe, Katrina; Peddle-McIntyre, Carolyn J; Bowyer, Samantha; Hawkins, Felicity; Jeffery, Emily; Chih, Hui Jun; Creaney, Jenette; Nowak, Anna; Brims, Fraser.
Afiliação
  • Hoon SN; Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Fyfe K; Curtin Medical School, Curtin University, Perth, Western Australia, Australia.
  • Peddle-McIntyre CJ; Curtin Medical School, Curtin University, Perth, Western Australia, Australia.
  • Bowyer S; Institute of Respiratory Health, Nedlands, Western Australia, Australia.
  • Hawkins F; Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Jeffery E; Institute of Respiratory Health, Nedlands, Western Australia, Australia.
  • Chih HJ; Exercise Medicine Research Institute, Edith Cowan University-Joondalup Campus, Joondalup, Western Australia, Australia.
  • Creaney J; Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Nowak A; Palliative Care, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Brims F; School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.
BMJ Open Respir Res ; 7(1)2020 03.
Article em En | MEDLINE | ID: mdl-32213537
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Caquexia / Estimulantes do Apetite / Mesotelioma Maligno / Hidrazinas Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Caquexia / Estimulantes do Apetite / Mesotelioma Maligno / Hidrazinas Idioma: En Ano de publicação: 2020 Tipo de documento: Article